Search company, investor...

Predict your next investment

Private Equity

Oppenheimer Private Equity Investments

oppenheim.de

Investments

11

Portfolio Exits

8

About Oppenheimer Private Equity Investments

Headquarters Location

Germany

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.
Submit portfolio details

Oppenheimer Private Equity Investments Investments

11 Investments

Oppenheimer Private Equity Investments has made 11 investments. Their latest investment was in Mast Therapeutics as part of their Private Equity on April 4, 2004.

CBI Logo

Oppenheimer Private Equity Investments Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/19/2004

Private Equity

Mast Therapeutics

$15.38M

Yes

Alpha Capital Partners, Anasazi Partners, Bristol Capital Advisors, BSI, BSI-New Biomedical Frontier, Carpe Diem Capital Management, Castle Creek Capital, Centrum Bank, Crestview Capital Funds, Enable Capital Management, Gamma Capital Partners, Greenwich Growth Fund, Heights Capital Management, JIBS Equities, Laddcap Value Advisors, LB Swiss Investment, LRG Capital Group, North Sound Capital, OTAPE Investments, Platinum Management, ProMed Capital, Ritchie Capital Management, Rock Hill Investment Management, Saad Investments Company, Schroders, SDS Capital Partners, SF Capital Group, Stone Street Capital, TCMP3 Capital, Viking Asset Management, Whalehaven Capital, Xmark Asset Management, and Xmark Funds

9/19/2003

Private Equity

Synovis Life Technologies

$39M

Yes

Acqua Wellington Asset Management, Argonaut Capital Management Corporation, Bernay Box, Bridgeway Capital Management, Downsview Capital, First Investors Management Company, Heights Capital Management, Highbridge Capital Management, Iroquois Capital Group, Langley Capital, LibertyView Capital Management, Lionsgate, LRG Capital Group, North Sound Capital, Phoenix Partners, ProMed Capital, Silver Oak Investments, and Tacony Investment Partnership

4/5/2001

Series C

BuildOnline

$15M

No

BancBoston Capital, Delta Private Equity Partners, ETF Group, Goldman Sachs, Upfront Ventures, and VPSA

3/9/2001

Series B

Subscribe to see more

$99M

Subscribe to see more

Subscribe to see more

0

10/23/2000

Series C

Subscribe to see more

$99M

Subscribe to see more

0

Date

4/19/2004

9/19/2003

4/5/2001

3/9/2001

10/23/2000

Round

Private Equity

Private Equity

Series C

Series B

Series C

Company

Mast Therapeutics

Synovis Life Technologies

BuildOnline

Subscribe to see more

Subscribe to see more

Amount

$15.38M

$39M

$15M

$99M

$99M

New?

Yes

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Alpha Capital Partners, Anasazi Partners, Bristol Capital Advisors, BSI, BSI-New Biomedical Frontier, Carpe Diem Capital Management, Castle Creek Capital, Centrum Bank, Crestview Capital Funds, Enable Capital Management, Gamma Capital Partners, Greenwich Growth Fund, Heights Capital Management, JIBS Equities, Laddcap Value Advisors, LB Swiss Investment, LRG Capital Group, North Sound Capital, OTAPE Investments, Platinum Management, ProMed Capital, Ritchie Capital Management, Rock Hill Investment Management, Saad Investments Company, Schroders, SDS Capital Partners, SF Capital Group, Stone Street Capital, TCMP3 Capital, Viking Asset Management, Whalehaven Capital, Xmark Asset Management, and Xmark Funds

Acqua Wellington Asset Management, Argonaut Capital Management Corporation, Bernay Box, Bridgeway Capital Management, Downsview Capital, First Investors Management Company, Heights Capital Management, Highbridge Capital Management, Iroquois Capital Group, Langley Capital, LibertyView Capital Management, Lionsgate, LRG Capital Group, North Sound Capital, Phoenix Partners, ProMed Capital, Silver Oak Investments, and Tacony Investment Partnership

BancBoston Capital, Delta Private Equity Partners, ETF Group, Goldman Sachs, Upfront Ventures, and VPSA

Subscribe to see more

Sources

0

0

Oppenheimer Private Equity Investments Portfolio Exits

8 Portfolio Exits

Oppenheimer Private Equity Investments has 8 portfolio exits. Their latest portfolio exit was Singing Machine on May 24, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

5/24/2022

IPO

Singing Machine

$99M

Public

5

8/18/2009

Acq - P2P

Subscribe to see more

$99M

Subscribe to see more

0

12/8/2006

Acquired

Subscribe to see more

$99M

Subscribe to see more

0

6/29/2006

Merger

Subscribe to see more

$99M

Subscribe to see more

10

9/9/2004

IPO

Subscribe to see more

$99M

Subscribe to see more

0

Date

5/24/2022

8/18/2009

12/8/2006

6/29/2006

9/9/2004

Exit

IPO

Acq - P2P

Acquired

Merger

IPO

Companies

Singing Machine

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

5

0

0

10

0

Oppenheimer Private Equity Investments Team

2 Team Members

Oppenheimer Private Equity Investments has 2 team members, including former Chief Financial Officer, Edgar Pirscher.

Name

Work History

Title

Status

Edgar Pirscher

Allianz Global Investors, and Commerzbank

Chief Financial Officer

Former

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Edgar Pirscher

Subscribe to see more

Work History

Allianz Global Investors, and Commerzbank

Title

Chief Financial Officer

Subscribe to see more

Status

Former

Subscribe to see more

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.